companydata.dkRenescience A/S: Financial statements 2017
CVR: 31846803
Renescience A/S (CVR 31846803) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -9,657,000 and a net result of DKK -7,760,000 compared with DKK -29,521,000 the year before. Equity amounted to DKK 81,786,000. The solvency ratio was 91.6%.
- Gross Profit
- -9,657,000 kr.
- Profit/Loss
- -7,760,000 kr.
- Equity
- 81,786,000 kr.
- Total Assets
- 89,250,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -9.7 mio. | -7.8 mio. | 81.8 mio. | - |
| 2016 | - | -37.1 mio. | -29.5 mio. | 89.5 mio. | - |
| 2015 | - | -56 mio. | -43.2 mio. | 24.1 mio. | - |
| 2014 | - | -26.4 mio. | -19.4 mio. | 33.3 mio. | - |
| 2013 | - | -25.6 mio. | -19.9 mio. | 27.7 mio. | - |
Find more companies like Renescience A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
As of June 8, 2017, Mikael Brandt has joined the board of directors of Renescience A/S.
As of June 8, 2017, Jacob Moesgård has left the board of directors of Renescience A/S.
Renescience A/S has published its annual report for 2016. Gross profit came to DKK -37,068,000, and the net result was DKK -29,521,000.
As of February 23, 2017, Hannes Reuter is registered as director of Renescience A/S.
As of February 23, 2017, Anna-Lena Elisabet Jeppsson has stepped down as director of Renescience A/S.
About Renescience A/S
Renescience A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lars Holm Lerke-Møller. The company is owned by Ørsted New Bio Solutions Holding A/S. In 2025, the company reported revenue of DKK 21,000 and a net result of DKK -503,937,000 compared with DKK -23,904,000 the year before. Equity amounted to DKK 73,470,000.